BIOHALE

Produktbeschreibung

BioHale® portfolio, comprised by BioHale® Sucrose and BioHale® Trehalose Dihydrate, can be used in various administration forms, such as for parenteral, inhalation, oral or ophthalmic route. BioHale® enables the stabilization of biologics in biopharmaceutical formulations and among many other biologic treatments, BioHale® is already used in several of the current vaccines against COVID-19. BioHale® portfolio ensures highest purity of excipients low in endotoxin.

Produktmerkmale

• Vaccine Adjuvant
• Stabiliser